Skip to main content
Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.47
-0.01 (-0.15%)
Jun 27, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024
Period Ending
 Dec '24
Medicines for Childhood and Adult Diseases with Equal Intensity
131.16M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024
Period Ending
 Dec '24
United States
131.16M